Light therapy during brain surgery shows promise in small pilot trial
NCT ID NCT03048240
First seen Feb 05, 2026 · Last updated May 21, 2026 · Updated 19 times
Summary
This small pilot study tested whether adding a light-activated drug treatment during surgery is safe and feasible for people with glioblastoma, an aggressive brain cancer. Ten patients received the therapy alongside standard surgery and chemoradiation. The main goal was to see if at least 6 out of 10 patients could complete the full treatment without severe, unexpected side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Roger Salengro, CHRU
Lille, France
Conditions
Explore the condition pages connected to this study.